Detection of Histone Modification by Chromatin Immunoprecipitation Combined Zinc Finger Luciferase-Based Bioluminescence Resonance Energy Transfer Assay
- 1 June 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 85 (13) , 6485-6490
Abstract
Epigenetic modification such as DNA methylation and histone modification have important roles in gene regulation. Epigenetic modification can be altered by environmental influences and are related to diseases. Therefore, epigenetic modifications may serve as biomarkers. In this study, we developed a convenient histone modification detection system by combining a chromatin immunoprecipitation (ChIP) and bioluminescence resonance energy transfer (BRET)-based homogeneous PCR product detection system using zinc finger fused to luciferase (ZF–luciferase) with DNA intercalating dye (ChIP-ZF-BRET assay). The ChIP-ZF-BRET assay comprises the following 3 steps: (1) ChIP, (2) PCR amplification of the target genomic region, which includes a zinc-finger recognition site, and (3) homogeneous detection of the PCR product by BRET using ZF–luciferase and fluorescent DNA intercalating dye. Using this system, we conveniently and accurately detected target histone modification at the androgen receptor gene promoter region in LNCaP and Du145 cells. The system can be applicable to DNA methylation detection using a methyl-CpG-binding domain protein or methylcytidine antibody instead of histone modification antibodies. Therefore, it may be useful and convenient for simultaneous detection of histone modification and DNA methylation in clinical diagnoses.Keywords
This publication has 28 references indexed in Scilit:
- Epigenetic biomarkers in prostate cancer: Current and future usesCancer Letters, 2014
- Epigenetic protein families: a new frontier for drug discoveryNature Reviews Drug Discovery, 2012
- DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing MemoryCancer Research, 2012
- Cancer Epigenetics: Modifications, Screening, and TherapyAnnual Review of Medicine, 2008
- A Chromatin Landmark and Transcription Initiation at Most Promoters in Human CellsCell, 2007
- Histone modifications as markers of cancer prognosis: a cellular viewBritish Journal of Cancer, 2007
- A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatinGenes & Development, 2004
- The language of covalent histone modificationsNature, 2000
- DNA hypomethylation leads to elevated mutation ratesNature, 1998
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992